US2014037727A1PendingUtilityA1
Tablet Of Paracetamol Containing An Encapsulated Flavorant
Est. expiryApr 5, 2026(expired)· nominal 20-yr term from priority
Inventors:Paul Field
A61K 9/2095A61K 45/06A61K 9/2013A61K 31/167A61K 9/2027A61K 31/137A61K 9/2054A61K 9/0095A61K 9/16
59
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A medicament tablet containing paracetamol (acetaminophen) as the (or an) active ingredient, and an encapsulated flavorant. The tablet may be swallowed in tablet form or may be dissolved or dispersed in water to form a palatable drink.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A medicament tablet comprising:
paracetamol; and an encapsulated flavorant.
2 . The tablet of claim 1 comprising from 200-800 mg of paracetamol.
3 . The medicament tablet of claim 1 further comprising a disintegration aid;
wherein the tablet is suitable to be swallowed in tablet form, but also disperses or dissolves in water to produce a palatable drink.
4 . The medicament tablet of claim 1 further comprising a URT aid selected from the group consisting of dextromethorphan, noscapine, ethyl morphine, theobromine, pholcodine, codeine, oxymetazoline, phenylephrine, pseudoephedrine, diphenhydramine, guaifenesin and ambroxol.
5 . The medicament tablet of claim 1 further comprising another analgesic medicament selected from the group consisting of ibuprofen, flurbiprofen, buprenorphine, aspirin, codeine, celecoxib, diclofenac, ketoprofen, meloxicam, naproxen and rofecoxib.
6 . The tablet of claim 3 , wherein the disintegration aid comprises a water-swellable polymer.
7 . The tablet of claim 3 comprising from 20-200 mg of the disintegration aid.
8 . The tablet of claim 6 , wherein the water-swellable polymer comprises crospovidone.
9 . A medicament tablet comprising:
from 200-800 mg of paracetamol; an encapsulated flavorant; from 20-200 mg of a disintegration aid; a URT aid selected from the group consisting of dextromethorphan, noscapine, ethyl morphine, theobromine, pholcodine, codeine, oxymetazoline, phenylephrine, pseudoephedrine, diphenhydramine, guaifenesin and ambroxol; and another analgesic medicament selected from the group consisting of ibuprofen, flurbiprofen, buprenorphine, aspirin, codeine, celecoxib, diclofenac, ketoprofen, meloxicam, naproxen and rofecoxib; wherein the tablet is suitable to be swallowed in tablet form, but also disperses or dissolves in water to produce a palatable drink.
10 . The tablet of claim 9 , wherein the disintegration aid comprises a water-swellable polymer.
11 . The tablet of claim 10 , wherein the water-swellable polymer comprises crospovidone.
12 . A medicament tablet comprising:
paracetamol; encapsulated flavorant; disintegration aid; binder; pressing aid; organic acid/salt flavorant; and sweetening agent.
13 . The tablet of claim 12 , wherein the tablet weight is within a weight range of from 700 to 1400 mg, and wherein the tablet has the following characteristics:
its friability does not exceed 2% as determined by Ph Eur monograph method 2.9.7; its hardness is in the range 8-26 kp as determined by Ph Eur monograph method 2.9.8; it is palatable when taken as a tablet; and it dissolves quickly in water to produce a palatable drink.
14 . The tablet of claim 12 , wherein the components comprise the following weight ranges:
Component
Weight Range (mg)
paracetamol
200-800
encapsulated flavorant
40-240
disintegration aid
20-200
binder
20-200
pressing aid
2-50
organic acid/salt flavorant
10-100
sweetening agent
10-80
15 . The tablet of claim 14 , wherein the tablet weight is within a weight range of from 700 to 1400 mg, and wherein the tablet has the following characteristics:
its friability does not exceed 2% as determined by Ph Eur monograph method 2.9.7; its hardness is in the range 8-26 kp as determined by Ph Eur monograph method 2.9.8; it is palatable when taken as a tablet; and it dissolves quickly in water to produce a palatable drink.
16 . A method of making the tablet of claim 1 comprising compressing paracetamol and an encapsulated flavorant.
17 . The method according to claim 16 , wherein the form of paracetamol and encapsulated flavorant is each individually selected from the group consisting of powder and granules.
18 . The method according to claim 17 comprising a direct tabletting method.
19 . The method according to claim 17 , wherein the method does not include a heating or warming step.
20 . The method according to claim 17 , wherein the method does not include wet granulation.
21 . The method according to claim 17 , wherein the method includes the addition of the encapsulated flavorant substantially at the stage when paracetamol is mixed with any other ingredients that may be present.Join the waitlist — get patent alerts
Track US2014037727A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.